Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMS-984923 is an orally available and blood-brain barrier permeable mGluR5 silencing allosteric modulator that inhibits β-amyloid oligomer-induced aberrant synaptic signaling, and can be used to study Alzheimer's disease.
Description | BMS-984923 is an orally available and blood-brain barrier permeable mGluR5 silencing allosteric modulator that inhibits β-amyloid oligomer-induced aberrant synaptic signaling, and can be used to study Alzheimer's disease. |
In vivo | BMS-984923 (7.5 mg/kg or 15 mg/kg, oral gavage, once) exhibited good oral bioavailability and BBB permeability in C57Bl6J male mice ( 7.5 mg/kg or 15 mg/kg, oral gavage, once); resulting in plasma concentrations exceeding 2 μM at 10 hours. Brain concentrations were almost as high as plasma concentrations when measured 3 hours after the 7.5 mg/kg oral dose [1]. |
Alias | BMS984923, BMS 984923 |
Molecular Weight | 374.82 |
Formula | C22H15ClN2O2 |
Cas No. | 1375752-78-5 |
Smiles | ClC1=C([C@@H]2[C@H](NC(=O)O2)C=3C=C(C#CC4=CC=CC=C4)C=NC3)C=CC=C1 |
Relative Density. | 1.38 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (80.04 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.